Mikart
Mikart specializes in the development, manufacturing, and packaging of solid-dose and liquid-oral dose products.
Mikart specializes in the development, manufacturing, and packaging of solid-dose and liquid-oral dose products. The company’s services include formulation development; analytical, manufacturing, packaging, and regulatory services; and complete project management. Mikart offers clients more than 40 years of experience, a responsive working relationship, and the ability to take products from formulation development through full-scale commercial production.
Mikart, Inc.
www.mikart.com
tel. 404.351.4510
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
